OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
Updated Adjuvant Atezolizumab Data (& more)
15 minutes
Posted Aug 11, 2022 at 8:02 pm.
0:00
15:18
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
New OS data is out for adjuvant atezolizumab in NSCLC - how does it compare to the original DFS data?
Plus, lots of recent FDA expanded approvals to discuss.
Previous
The Infamous Erlotinib Study
Next
HER2 Mutated NSCLC
← See all 273 episodes of OncoPharm